Ascentage Pharma to Participate in Four Upcoming Investor Conferences

On September 2, 2026 Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855) ("Ascentage Pharma" or the "Company"), a global, commercial-stage, integrated biopharmaceutical company engaged in the discovery, development and commercialization of novel, differentiated therapies to address unmet medical needs in cancer, reported that the Company’s management will participate in four upcoming investor conferences in New York, New York.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Citi’s 2026 Biopharma Back to School Conference
Format: Fireside chat and one-on-one investor meetings
Date and Time: Wednesday, September 9, 2026, 4:20 p.m. to 4:55 p.m. ET
Location: JW Marriott Essex House, 160 Central Park South, New York, NY

H.C. Wainwright 28th Annual Global Investment Conference
Format: Company presentation and one-on-one investor meetings
Date and Time: Monday, September 14, 2026, 9:00 a.m. to 9:30 a.m. ET
Location: Lotte New York Palace Hotel, 455 Madison Avenue, New York, NY

Deutsche Bank 2026 Healthcare Summit
Format: Company presentation and one-on-one investor meetings
Date: Wednesday, September 16 – Thursday, September 17, 2026
Location: Deutsche Bank Center, One Columbus Circle, New York, NY

Bernstein Insights: Healthcare Leaders and Disruptors 3rd Annual Healthcare Forum
Format: Company presentation and one-on-one investor meetings
Date: Wednesday, September 23 – Thursday, September 24, 2026
Location: New York, NY

Investors interested in scheduling a meeting with the Ascentage Pharma management team should contact their conference representative.

(Press release, Ascentage Pharma, SEP 2, 2026, View Source [SID1234670566])